Developer docs
API playgroundTry for free, no card

Search company profiles

Monash IVF

Full company profile

uuid02loaxc

Namestring
Monash IVF
Legal namestring
Monash IVF Group
Websiteurl
monashivf.com
Company typeenum
Private
Founded yearint
1972
Descriptiontext

Monash IVF is a leading Australian fertility services provider operating 112 clinic locations across metropolitan and regional Australia. Founded in 1972 as one of Australia's pioneering IVF programs, the company has helped bring over 70,000 babies into the world over 50+ years. Its service portfolio spans the full reproductive journey: assisted reproductive technologies (IVF, ICSI, IUI), fertility preservation (egg and sperm freezing), donor programs (sperm, eggs, embryos), surrogacy, genetic testing (PGT-M, PGT-A, NIPT/nest, carrier screening), and complementary care including psychological support and acupuncture.

The technology platform centers on a purpose-built flagship laboratory at Cremorne (Melbourne) featuring time-lapse embryo monitoring incubators and Piezo-ICSI technology, alongside proprietary R&D including a wearable hormone biosensor in development with Symex Labs targeting early 2028 commercialisation. Monash IVF pioneered egg vitrification and achieved the world's first birth from a vitrified egg in 1999, and its Cremorne clinic reports a 46% pregnancy rate for frozen embryo transfers vs. <40% national average (ANZARD), with 52% for patients aged 35-39. Clinical leadership comprises multiple CREI-subspecialist qualified fertility specialists led by Group Medical Director Prof Luk Rombauts and Chief Scientific Officer Prof Deirdre Zander-Fox.

Monash IVF generates revenue primarily through fee-for-service fertility treatments, specialist consultations, fertility health checks, and ancillary services such as ultrasound and genetic testing. Pricing is personalised rather than publicly listed, with Medicare rebates available for eligible patients and financing options including Zip Money, TLC Payment Plans, and superannuation access. Go-to-market combines direct-to-consumer digital marketing, a free nurse enquiry team (1800 628 533), GP and medical professional referrals, webinars and events, and on-site specialist consultations across its clinic network, targeting individuals and couples experiencing infertility, LGBTQIA+ families, single individuals, women delaying parenthood, and Queensland public servants with new Reproductive Health Leave entitlements.

Short descriptiontext

Monash IVF is an Australian fertility services provider operating 112 clinic locations, offering IVF, ICSI, IUI, fertility preservation, donor programs, and genetic testing to individuals and couples across Australia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersClayton, Australia
HQ citystring
Clayton
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices32 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fertility treatment services, in vitro fertilisation, reproductive healthcare, fertility preservation, assisted reproductive technology
Industry4 codes
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAKADAI
Reproductive Endocrinology & Infertility (Endocrine)
NAICS code2 codes
  • Family Planning Centers62141
  • Family Planning Centers621410
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Reproductive Healthcare and Fertility Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Fertility Treatment Services
TypeTransaction Fee
Description

Monash IVF generates revenue primarily through providing fee-for-service fertility treatments including IVF, ICSI, IUI, egg freezing, sperm freezing, donor services, genetic testing, ovulation induction, and related procedures. Treatments are priced individually with transparent inclusions, and Medicare rebates are available for eligible patients.

monashivf.com
2Consultation and Specialist Services
TypeProfessional Services
Description

Revenue from specialist fertility consultations, fertility health checks, telehealth appointments, and nursing enquiry services. Initial nurse chats are free; specialist consultations and fertility health checks generate revenue.

monashivf.com
3Payment Plans and Financing
TypeManaged Services
Description

Monash IVF offers payment options including Zip Money, TLC Payment Plans, and the ability to access superannuation for IVF treatment, providing financing solutions that may facilitate higher treatment uptake.

monashivf.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details2 tiers
1Treatment costs vary by individual plan; transparent pricing with clear inclusions and flexible payment options
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

IVF and treatment costs are personalized. Medicare rebates apply. Payment options include Zip Money, TLC Payment Plans, and superannuation access.

monashivf.com
2Free initial nurse enquiry service
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free 15-minute nurse chat, complimentary for prospective patients to discuss options before committing to paid specialist consultations or treatment.

monashivf.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1nest
Description

Non-Invasive Prenatal Screening Test (NIPT) offering accurate screening for common chromosome conditions from 10 weeks of pregnancy.

monashivf.com
Core offering1 text field

Monash IVF provides assisted reproductive technology and integrated fertility care across Australia, with core treatments including IVF, ICSI, IUI, fertility preservation (egg and sperm freezing), donor and surrogacy programs, preimplantation and prenatal genetic testing, and complementary diagnostic services (fertility health checks, AMH testing, semen analysis, ovulation induction, ultrasound). The company supports patients across the full reproductive journey, from fertility assessment and treatment through to early pregnancy care, operating 112 locations and a flagship full-service clinic at Cremorne with on-site laboratory and day hospital.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Over 70,000 babies born through Monash IVF services since founding
+5 more records
Product overview1 text field

Monash IVF is a leading Australian fertility provider offering a comprehensive, integrated fertility care platform spanning the entire reproductive journey. The core offering centres on assisted reproductive technologies (IVF, ICSI, IUI) and fertility preservation (egg freezing, sperm freezing), supported by donor programs (sperm, eggs, embryos) and surrogacy services. The portfolio includes genetic testing modules (PGT-M, PGT-A, NIPT/nest, carrier screening) and diagnostic services (fertility health checks, AMH testing, semen analysis, ultrasound). Supporting services include psychological support, complementary therapies, and patient education programs (Ready Set Baby). The organisation operates 112 locations across Australia with flagship full-service clinics featuring on-site laboratories and day hospitals. Research and innovation are embedded through initiatives like the Fertility Insights Index and partnerships for emerging technologies (hormone biosensors, Piezo-ICSI).

Product and service18 records
1IVF - In Vitro Fertilisation
CategoryAssisted Reproductive Treatment
Description

Primary fertility treatment involving ovarian stimulation, egg retrieval, laboratory fertilisation of eggs and sperm, and embryo transfer. Includes transparent inclusions and Medicare-rebate eligible components.

2ICSI - Intracytoplasmic Sperm Injection
CategoryAssisted Reproductive Treatment
Description

Microscopic sperm injection technique where a single sperm is injected directly into an egg to achieve fertilisation, primarily used for male-factor infertility.

3IUI - Assisted Insemination
CategoryAssisted Reproductive Treatment
Description

Intrauterine insemination procedure placing washed sperm directly into the uterus during ovulation, a less invasive fertility treatment option than IVF.

4Egg Freezing
CategoryFertility Preservation
Description

Fertility preservation service using vitrification to freeze and store unfertilised eggs. Monash IVF pioneered this method and achieved the world's first birth from a vitrified egg in 1999.

5Sperm Freezing
CategoryFertility Preservation
Description

Fertility preservation service for freezing and long-term storage of sperm samples for individuals and couples.

6Donor Sperm Program
CategoryDonor Program
Description

Donor sperm service for individuals and couples requiring donor conception, including same-sex couples and single women seeking IUI or IVF with donor sperm.

7Donor Eggs Program
CategoryDonor Program
Description

Donor egg service for individuals and couples unable to use their own eggs, including overseas donor egg programs for patients such as same-sex couples.

8Embryo Donation Program
CategoryDonor Program
Description

Donated embryo service allowing recipients to receive embryos donated by other IVF patients who have completed their families.

9Surrogacy Program
CategoryDonor Program
Description

Surrogacy arrangement support for individuals and couples needing a gestational carrier to build their families.

10PGT-M - Preimplantation Genetic Testing for Single Gene Conditions
CategoryGenetic Testing
Description

Preimplantation genetic testing to identify single-gene disorders such as cystic fibrosis or Huntington's disease before embryo transfer.

11PGT-A - Preimplantation Genetic Testing for Aneuploidy
CategoryGenetic Testing
Description

Preimplantation genetic testing to screen embryos for chromosomal aneuploidy to improve implantation success rates and reduce miscarriage risk.

12nest - Non-Invasive Prenatal Screening Test (NIPT)
CategoryGenetic Testing
Description

Non-invasive prenatal screening test available from 10 weeks offering accurate screening for common chromosome conditions. nest+ provides additional genome-wide insights at no extra cost, with samples analysed in Australia by experienced genetic scientists.

13Genetic Carrier Screening
CategoryGenetic Testing
Description

Population-based screening test for hundreds of genes to identify carriers of genetic conditions, available via saliva kit or blood test at partner pathology centres.

14Fertility Health Check
CategoryEarly Intervention and Diagnostics
Description

Comprehensive fertility assessment including blood tests for six hormones and viral immunity, semen analysis, optional ultrasound, and a telehealth consultation with a fertility GP to discuss results and treatment pathways.

15AMH Blood Test
CategoryEarly Intervention and Diagnostics
Description

Anti-Müllerian Hormone blood test to assess ovarian reserve and female fertility potential.

16Semen Analysis
CategoryEarly Intervention and Diagnostics
Description

Laboratory analysis evaluating sperm count, size, shape, and movement to assess male fertility.

17Ovulation Induction
CategoryEarly Intervention and Diagnostics
Description

Medication-based treatment to stimulate ovulation in women with irregular or absent ovulation cycles.

18Ultrasound Services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-13
Description

Monash IVF has announced a company-wide partnership with women's charity Share the Dignity to ensure women, girls and people who menstruate facing hardship have access to essential period products. Monash IVF staff across the country will participate in fundraising, hygiene bag packing and other initiatives. Share the Dignity works with more than 3,000 charities and has received more than six million period product donations to date.

2Symex Labs
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

Monash IVF partnered with Melbourne start-up Symex Labs to develop a world-first wearable hormone biosensor using microneedle technology to continuously monitor progesterone and estradiol levels for IVF patients. The patch will send results directly to the clinical team to determine optimal timing for egg collection or embryo transfer. First in-human pilot study expected within 12 months, commercialization planned for early 2028. Research received $2.5 million in funding from a joint initiative including Monash IVF, Australian Government, University of Melbourne's Genesis Fund, RMIT and Breakthrough Victoria.

monashivf.com
3Monash University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Monash IVF is affiliated with Monash University, with Prof Luk Rombauts holding an Adjunct Clinical Professor appointment in the Department of Obstetrics and Gynaecology. The partnership includes plans for an Australian-first mitochondrial donation clinical trial at the Cremorne facility, pending regulatory approvals. Also research collaboration with Ritchie Centre at Monash University (Dr Luke Larmour's research background).

monashivf.com
4Cremorne Private Day Surgery
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership between Monash IVF and Cremorne Private Day Surgery, a purpose-built licensed day hospital at 510 Church Street, Cremorne. The facility includes a state-of-the-art laboratory, two operating theatres for fertility and gynecological procedures, and is accredited with National Safety and Quality Health Service Standards (NSQHSS).

monashivf.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Monash IVF Group invested in specialist ultrasound services through the acquisition of Ultrasound North, strengthening integrated ultrasound and reproductive care network for Perth patients.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Affiliate clinic Fertility North in Joondalup (WA) through which Monash IVF offers Piezo-ICSI technology and other fertility services, extending reach to Perth's northern suburbs.

Strategic tierMinorTypeGTM or Marketing Partner
Description

AFL player Darcy Cameron publicly shared his experience with genetic testing through Monash IVF, encouraging prospective parents to consider testing. Represents organic community ambassador/GTM partnership through public story sharing.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of Australia's largest fertility and IVF networks with multiple clinics across Australia and Ireland; directly competes with Monash IVF on IVF, ICSI, genetic testing and fertility preservation services for the same Australian patient base.

TypeDirect peer
Description

Major Australian fertility clinic group with a strong Sydney base and multiple sites offering IVF, ICSI, preimplantation genetic testing and fertility preservation; competes head-to-head with Monash IVF in NSW and other metro markets.

TypeDirect peer
Description

UK-based fertility clinic group offering IVF, ICSI, genetic testing and donor services; comparable in service mix and patient journey to Monash IVF, providing a cross-market ART operator benchmark.

TypeDirect peer
Description

Australian fertility clinic group operating lower-cost IVF programs; competes on price-accessible IVF cycles in the same patient demographics as Monash IVF across metro and regional Australia.

TypeDirect peer
Description

Australian IVF and fertility services provider with clinics across QLD, NSW, VIC and SA; offers the same core ART services, donor programs and genetic testing, targeting similar consumer patient segments.

TypeBroad incumbent
Description

Global medical device and fertility solutions provider offering ART lab consumables, IVF media and PGT services; overlaps with Monash IVF where its genomics and lab services intersect in the IVF workflow.

TypeDirect peer
Description

Large US fertility clinic network with extensive clinical and embryology services including shared-risk programmes; comparable international benchmark for scale, technology adoption and integrated reproductive care.

TypeDirect peer
Description

Provider of fertility and IVF services across South Australia and the Northern Territory; offers standard ART and advanced reproductive technologies as an alternative provider to Monash IVF in regional markets.

9NH Diagnostics (no major listing)
TypeDirect peer
Description

UK and European fertility clinic operator (TFP/The Fertility Partnership) running IVF, ICSI, donor and genetic testing programmes under a multi-clinic hub-and-spoke model that mirrors Monash IVF's Australian footprint.

TypeBroad incumbent
Description

Genomics platform provider enabling PGT-A, PGT-M and NIPT services used across the fertility sector; relevant adjacent comparator given Monash IVF's reliance on genetic testing as a service-line extension.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Monash IVF

Reproductive Healthcare and Fertility Servicesmonashivf.com

Monash IVF is an Australian fertility services provider operating 112 clinic locations, offering IVF, ICSI, IUI, fertility preservation, donor programs, and genetic testing to individuals and couples across Australia.

What Monash IVF does

Monash IVF is a leading Australian fertility services provider operating 112 clinic locations across metropolitan and regional Australia. Founded in 1972 as one of Australia's pioneering IVF programs, the company has helped bring over 70,000 babies into the world over 50+ years. Its service portfolio spans the full reproductive journey: assisted reproductive technologies (IVF, ICSI, IUI), fertility preservation (egg and sperm freezing), donor programs (sperm, eggs, embryos), surrogacy, genetic testing (PGT-M, PGT-A, NIPT/nest, carrier screening), and complementary care including psychological support and acupuncture.

The technology platform centers on a purpose-built flagship laboratory at Cremorne (Melbourne) featuring time-lapse embryo monitoring incubators and Piezo-ICSI technology, alongside proprietary R&D including a wearable hormone biosensor in development with Symex Labs targeting early 2028 commercialisation. Monash IVF pioneered egg vitrification and achieved the world's first birth from a vitrified egg in 1999, and its Cremorne clinic reports a 46% pregnancy rate for frozen embryo transfers vs. <40% national average (ANZARD), with 52% for patients aged 35-39. Clinical leadership comprises multiple CREI-subspecialist qualified fertility specialists led by Group Medical Director Prof Luk Rombauts and Chief Scientific Officer Prof Deirdre Zander-Fox.

Monash IVF generates revenue primarily through fee-for-service fertility treatments, specialist consultations, fertility health checks, and ancillary services such as ultrasound and genetic testing. Pricing is personalised rather than publicly listed, with Medicare rebates available for eligible patients and financing options including Zip Money, TLC Payment Plans, and superannuation access. Go-to-market combines direct-to-consumer digital marketing, a free nurse enquiry team (1800 628 533), GP and medical professional referrals, webinars and events, and on-site specialist consultations across its clinic network, targeting individuals and couples experiencing infertility, LGBTQIA+ families, single individuals, women delaying parenthood, and Queensland public servants with new Reproductive Health Leave entitlements.

Monash IVF firmographics

Firmographics
Name
Monash IVF
Legal name
Monash IVF Group
Website
https://monashivf.com
Company type
Private
Founded year
1972
Operating status
Operating
Headcount range
1–10 employees
Short description
Monash IVF is an Australian fertility services provider operating 112 clinic locations, offering IVF, ICSI, IUI, fertility preservation, donor programs, and genetic testing to individuals and couples across Australia.
Ownership category
akta.pro rank

Monash IVF industry classification

Industry
Product category
Reproductive Healthcare and Fertility Services
NAICS
Family Planning Centers (62141), Family Planning Centers (621410)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAKADAI
Reproductive Endocrinology & Infertility (Endocrine)

Keywords

  • Fertility treatment services
  • In vitro fertilisation
  • Reproductive healthcare
  • Fertility preservation
  • Assisted reproductive technology

Where Monash IVF is headquartered

Location

Headquarters

HQ city
Clayton
HQ country
Australia
HQ region
Oceania

Offices32 records

Markets served

Monash IVF business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Fertility Treatment Services: Monash IVF generates revenue primarily through providing fee-for-service fertility treatments including IVF, ICSI, IUI, egg freezing, sperm freezing, donor services, genetic testing, ovulation induction, and related procedures. Treatments are priced individually with transparent inclusions, and Medicare rebates are available for eligible patients.
  2. Consultation and Specialist Services: Revenue from specialist fertility consultations, fertility health checks, telehealth appointments, and nursing enquiry services. Initial nurse chats are free; specialist consultations and fertility health checks generate revenue.
  3. Payment Plans and Financing: Monash IVF offers payment options including Zip Money, TLC Payment Plans, and the ability to access superannuation for IVF treatment, providing financing solutions that may facilitate higher treatment uptake.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goTreatment costs vary by individual plan; transparent pricing with clear inclusions and flexible payment options
FreemiumPay-as-you-goFree initial nurse enquiry service

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Monash IVF product offering

Product offering

Core offering

Monash IVF provides assisted reproductive technology and integrated fertility care across Australia, with core treatments including IVF, ICSI, IUI, fertility preservation (egg and sperm freezing), donor and surrogacy programs, preimplantation and prenatal genetic testing, and complementary diagnostic services (fertility health checks, AMH testing, semen analysis, ovulation induction, ultrasound). The company supports patients across the full reproductive journey, from fertility assessment and treatment through to early pregnancy care, operating 112 locations and a flagship full-service clinic at Cremorne with on-site laboratory and day hospital.

Product overview

Monash IVF is a leading Australian fertility provider offering a comprehensive, integrated fertility care platform spanning the entire reproductive journey. The core offering centres on assisted reproductive technologies (IVF, ICSI, IUI) and fertility preservation (egg freezing, sperm freezing), supported by donor programs (sperm, eggs, embryos) and surrogacy services. The portfolio includes genetic testing modules (PGT-M, PGT-A, NIPT/nest, carrier screening) and diagnostic services (fertility health checks, AMH testing, semen analysis, ultrasound). Supporting services include psychological support, complementary therapies, and patient education programs (Ready Set Baby). The organisation operates 112 locations across Australia with flagship full-service clinics featuring on-site laboratories and day hospitals. Research and innovation are embedded through initiatives like the Fertility Insights Index and partnerships for emerging technologies (hormone biosensors, Piezo-ICSI).

Differentiator

Problem solved

Functional benefit

Brands

  • nest: Non-Invasive Prenatal Screening Test (NIPT) offering accurate screening for common chromosome conditions from 10 weeks of pregnancy.

Products and services

  • IVF - In Vitro Fertilisation Primary fertility treatment involving ovarian stimulation, egg retrieval, laboratory fertilisation of eggs and sperm, and embryo transfer. Includes transparent inclusions and Medicare-rebate eligible components.
  • ICSI - Intracytoplasmic Sperm Injection Microscopic sperm injection technique where a single sperm is injected directly into an egg to achieve fertilisation, primarily used for male-factor infertility.
  • IUI - Assisted Insemination Intrauterine insemination procedure placing washed sperm directly into the uterus during ovulation, a less invasive fertility treatment option than IVF.
  • Egg Freezing Fertility preservation service using vitrification to freeze and store unfertilised eggs. Monash IVF pioneered this method and achieved the world's first birth from a vitrified egg in 1999.
  • Sperm Freezing Fertility preservation service for freezing and long-term storage of sperm samples for individuals and couples.
  • Donor Sperm Program Donor sperm service for individuals and couples requiring donor conception, including same-sex couples and single women seeking IUI or IVF with donor sperm.
  • Donor Eggs Program Donor egg service for individuals and couples unable to use their own eggs, including overseas donor egg programs for patients such as same-sex couples.
  • Embryo Donation Program Donated embryo service allowing recipients to receive embryos donated by other IVF patients who have completed their families.
  • Surrogacy Program Surrogacy arrangement support for individuals and couples needing a gestational carrier to build their families.
  • PGT-M - Preimplantation Genetic Testing for Single Gene Conditions Preimplantation genetic testing to identify single-gene disorders such as cystic fibrosis or Huntington's disease before embryo transfer.
  • PGT-A - Preimplantation Genetic Testing for Aneuploidy Preimplantation genetic testing to screen embryos for chromosomal aneuploidy to improve implantation success rates and reduce miscarriage risk.
  • nest - Non-Invasive Prenatal Screening Test (NIPT) Non-invasive prenatal screening test available from 10 weeks offering accurate screening for common chromosome conditions. nest+ provides additional genome-wide insights at no extra cost, with samples analysed in Australia by experienced genetic scientists.
  • Genetic Carrier Screening Population-based screening test for hundreds of genes to identify carriers of genetic conditions, available via saliva kit or blood test at partner pathology centres.
  • Fertility Health Check Comprehensive fertility assessment including blood tests for six hormones and viral immunity, semen analysis, optional ultrasound, and a telehealth consultation with a fertility GP to discuss results and treatment pathways.
  • AMH Blood Test Anti-Müllerian Hormone blood test to assess ovarian reserve and female fertility potential.
  • Semen Analysis Laboratory analysis evaluating sperm count, size, shape, and movement to assess male fertility.
  • Ovulation Induction Medication-based treatment to stimulate ovulation in women with irregular or absent ovulation cycles.
  • Ultrasound Services

Quantifiable outcome

  • Over 70,000 babies born through Monash IVF services since founding
  • +5 more outcomes

Companies that use Monash IVF

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Monash IVF technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Monash IVF partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Share the DignitycoreStrategic or Co-development Partner · 13 March 2026Monash IVF has announced a company-wide partnership with women's charity Share the Dignity to ensure women, girls and people who menstruate facing hardship have access to essential period products. Monash IVF staff across the country will participate in fundraising, hygiene bag packing and other initiatives. Share the Dignity works with more than 3,000 charities and has received more than six million period product donations to date.
  • Symex LabscoreStrategic or Co-development Partner · 10 March 2026Monash IVF partnered with Melbourne start-up Symex Labs to develop a world-first wearable hormone biosensor using microneedle technology to continuously monitor progesterone and estradiol levels for IVF patients. The patch will send results directly to the clinical team to determine optimal timing for egg collection or embryo transfer. First in-human pilot study expected within 12 months, commercialization planned for early 2028. Research received $2.5 million in funding from a joint initiative including Monash IVF, Australian Government, University of Melbourne's Genesis Fund, RMIT and Breakthrough Victoria.
  • Monash UniversitycoreStrategic or Co-development PartnerMonash IVF is affiliated with Monash University, with Prof Luk Rombauts holding an Adjunct Clinical Professor appointment in the Department of Obstetrics and Gynaecology. The partnership includes plans for an Australian-first mitochondrial donation clinical trial at the Cremorne facility, pending regulatory approvals. Also research collaboration with Ritchie Centre at Monash University (Dr Luke Larmour's research background).
  • Cremorne Private Day SurgerycoreStrategic or Co-development PartnerPartnership between Monash IVF and Cremorne Private Day Surgery, a purpose-built licensed day hospital at 510 Church Street, Cremorne. The facility includes a state-of-the-art laboratory, two operating theatres for fertility and gynecological procedures, and is accredited with National Safety and Quality Health Service Standards (NSQHSS).
  • Ultrasound NorthminorStrategic or Co-development PartnerMonash IVF Group invested in specialist ultrasound services through the acquisition of Ultrasound North, strengthening integrated ultrasound and reproductive care network for Perth patients.
  • Fertility NorthminorChannel Partner/ Reseller/ DistributorAffiliate clinic Fertility North in Joondalup (WA) through which Monash IVF offers Piezo-ICSI technology and other fertility services, extending reach to Perth's northern suburbs.
  • Collingwood AFL (Darcy Cameron)minorGTM or Marketing PartnerAFL player Darcy Cameron publicly shared his experience with genetic testing through Monash IVF, encouraging prospective parents to consider testing. Represents organic community ambassador/GTM partnership through public story sharing.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Monash IVF competitors and assessment

Company assessment

Direct peers

  • Virtus Health: One of Australia's largest fertility and IVF networks with multiple clinics across Australia and Ireland; directly competes with Monash IVF on IVF, ICSI, genetic testing and fertility preservation services for the same Australian patient base.
  • Genea (formerly Sydney IVF): Major Australian fertility clinic group with a strong Sydney base and multiple sites offering IVF, ICSI, preimplantation genetic testing and fertility preservation; competes head-to-head with Monash IVF in NSW and other metro markets.
  • Care Fertility: UK-based fertility clinic group offering IVF, ICSI, genetic testing and donor services; comparable in service mix and patient journey to Monash IVF, providing a cross-market ART operator benchmark.
  • Adora Fertility: Australian fertility clinic group operating lower-cost IVF programs; competes on price-accessible IVF cycles in the same patient demographics as Monash IVF across metro and regional Australia.
  • City Fertility Centre: Australian IVF and fertility services provider with clinics across QLD, NSW, VIC and SA; offers the same core ART services, donor programs and genetic testing, targeting similar consumer patient segments.
  • Shady Grove Fertility (now part of US Fertility / Inception Fertility): Large US fertility clinic network with extensive clinical and embryology services including shared-risk programmes; comparable international benchmark for scale, technology adoption and integrated reproductive care.
  • Repromed (part of Genea group): Provider of fertility and IVF services across South Australia and the Northern Territory; offers standard ART and advanced reproductive technologies as an alternative provider to Monash IVF in regional markets.
  • NH Diagnostics (no major listing): UK and European fertility clinic operator (TFP/The Fertility Partnership) running IVF, ICSI, donor and genetic testing programmes under a multi-clinic hub-and-spoke model that mirrors Monash IVF's Australian footprint.

Broad incumbents

  • CooperSurgical (Fertility Solutions): Global medical device and fertility solutions provider offering ART lab consumables, IVF media and PGT services; overlaps with Monash IVF where its genomics and lab services intersect in the IVF workflow.
  • Illumina (Reproductive and Genetic Health): Genomics platform provider enabling PGT-A, PGT-M and NIPT services used across the fertility sector; relevant adjacent comparator given Monash IVF's reliance on genetic testing as a service-line extension.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Monash IVF social profiles

Digital presence

Monash IVF compliance and trust

Trust signal

Compliance1 record

Monash IVF financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Monash IVF leadership team

Management profile

Number of profiles

Profiles14 records

Monash IVF subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Monash IVF funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Monash IVF M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monash IVF

What does Monash IVF do?

Monash IVF provides assisted reproductive technology and integrated fertility care across Australia, with core treatments including IVF, ICSI, IUI, fertility preservation (egg and sperm freezing), donor and surrogacy programs, preimplantation and prenatal genetic testing, and complementary diagnostic services (fertility health checks, AMH testing, semen analysis, ovulation induction, ultrasound). The company supports patients across the full reproductive journey, from fertility assessment and treatment through to early pregnancy care, operating 112 locations and a flagship full-service clinic at Cremorne with on-site laboratory and day hospital.

Is Monash IVF a public or private company?

Monash IVF is a private company. It is classified as unknown and is currently operating.

When was Monash IVF founded?

Monash IVF was founded in 1972. It employs 1 to 10 people.

Where is Monash IVF based?

Monash IVF is headquartered in Clayton, Australia, in the Oceania region.

How does Monash IVF make money?

Three revenue lines are on record. Fertility Treatment Services are the primary driver. The others are consultation and Specialist Services and payment Plans and Financing.

Who are Monash IVF's main competitors?

Direct peers on record are Virtus Health, Genea (formerly Sydney IVF), Care Fertility, Adora Fertility, City Fertility Centre, Shady Grove Fertility (now part of US Fertility / Inception Fertility), Repromed (part of Genea group) and NH Diagnostics (no major listing). Broad incumbents are CooperSurgical (Fertility Solutions) and Illumina (Reproductive and Genetic Health).

Does Monash IVF have an API?

No public API is recorded for Monash IVF.

What industry is Monash IVF in?

Monash IVF's product category is Reproductive Healthcare and Fertility Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 62141 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The National Law ReviewAustralian Privacy Commissioner Determination on Pixel TrackingThe Australian Privacy Commissioner determined that Monash IVF and a telehealth company breached privacy laws by using tracking pixels to collect sensitive user data without consent. The investigation revealed that these entities targeted users with advertisements and matched them to social media accounts, violating specific Australian Privacy Principles regarding sensitive information collection and marketing.ABCMinister instructs Queensland Health to review fertility guidance after women's treatments disruptedQueensland's Health Minister Tim Nicholls has instructed the state's health department to review its fertility clinic guidance after same-sex couples were prevented from proceeding with fertility treatments due to updated rules on sperm donor family limits. The February 2024 guidance changed how family allocations are counted for lesbian couples using the same donor, effectively reducing available spots and disrupting treatments for women like Deborah Poerio, who was blocked from embryo transfer by Monash IVF. The review is expected to be completed within weeks, with the health minister acknowledging concerns about the department's interpretation of the law.ReutersA second Australian IVF mix-up shakes clinic and industryMonash IVF mistakenly implanted a patient with her own embryo instead of her partner's in a Melbourne clinic on June 5, a second mix-up. Shares fell 25% and the company extended its investigation, while regulators investigated. The incident raises concerns about IVF clinic oversight.WsjHealth Care Roundup: Market TalkMonash IVF's share price fell after a profit warning, with Jefferies citing discretionary IVF treatment and Victoria's economic challenges. The company lowered FY2025 guidance to A$27.5 million, and shares are down about 47% over 12 months. Jefferies sees potential corporate interest if an acquirer takes a longer-term view.ReutersAustralian woman gives birth to wrong couple's baby in IVF mix-upAn Australian woman gave birth to a stranger's baby after a Monash IVF doctor implanted the wrong embryo. The clinic apologized, blaming human error, and the stock fell 35%. The incident prompted extra audits and raised concerns about IVF clinic security.BBCMonash IVF: Woman gives birth to stranger's baby in Australia embryo mix-upA woman in Australia gave birth to a stranger's baby after Monash IVF mistakenly transferred another patient's embryos. The clinic, which paid a $56m settlement last year, launched an investigation and apologized to affected patients.Business Wire BlogChina In Vitro Fertilization Market Forecast Report and Company Analysis 2025-2033 Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash IVF, Maria Fertility, Bangkok Fertility Center, EMD SeronoChina's in vitro fertilization market is projected to grow from $5.77 billion in 2024 to $11.26 billion by 2033, a CAGR of 7.72%. Growth is driven by rising infertility rates, government support, and changing social attitudes, while challenges include high costs and limited clinic access.ABCMajor fertility clinic refuses to warn families after sperm donor tracks down a mum and her IVF-conceived sonA sperm donor tracked down a mother and her son, claiming harassment, prompting police to issue a family violence intervention order. Monash IVF refused to warn other families, citing no imminent threat. The mother has since complained to the industry regulator.ABCMore women are freezing their eggs for future pregnancies. But what if they aren't used?Fewer than 13% of patients at Monash IVF clinics used their frozen eggs between 2012 and 2021, with only 23 donating. Experts say women should be given more information about donating surplus eggs, and current rules limit research donation.htnAustralian fertility service provider Monash IVF partners with health tech start-up OX.DH – htnMonash IVF partnered with health tech start-up OX.DH to introduce its OX.ar assisted reproduction solution, providing portal access for patients to manage appointments and results. The Microsoft cloud-native platform aims to reduce administrative burden and support digital transformation, with security built on Microsoft Azure.